Fool.com
The World's Greatest Investing Community
Results 11 - 20 of 762 : Previous 1 2 3 4 5 6 7 8 9 Next
A Schizophrenic Move by Merck?
Issue $29 billion in shares, buy back $3 billion. Say what?
4-Star Stocks Poised to Pop: Merck
Market-trouncing returns could be written in these four stars.
The drugmaker slips through an advisory committee unscathed.
Why You Can't Afford to Miss These Stocks
Now is the time, or you'll regret it later.
The Government Won't Be There for You
Be prepared to pay for your own retirement.
A new erectile-dysfunction drug shows promise.
Glaxo and Nabi team up for smokers who want to quit.
A Big Upgrade for Sanofi-Aventis
This bullish call comes from more than just one analyst.
Music to Health-Care Investors' Ears
Are faster FDA review times coming?
The company makes a deal that could pay off big, but could flame out instead.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK